Skip to main content
SpringerLink
Log in

Useful tools for the Management of Atopic Dermatitis

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Eczema, frequently named atopic dermatitis, is the most frequent chronic skin disease of early childhood, with a high prevalence in industrialized countries and a relapsing-remitting course that is responsible for a serious burden on affected children and their families. Even though most facets of this disease are nowadays well known and numerous guidelines are available, some confusion still exists regarding certain aspects. First, several names have been proposed for the disorder. We suggest that the name and definition adopted by the World Allergy Organization should be used: ‘eczema,’ divided into ‘atopic,’ when an allergic sensitization can be demonstrated, and ‘non-atopic,’ in the absence of sensitization.

Several diagnostic criteria have been proposed, but at present the two most reliable are the 2003 revision by the American Academy of Dermatology of the Hanifin-Rajka criteria, and those by Williams revised in 2005. To date, 20 different clinical scores have been published to assess the severity; however, only the EASI (Eczema Area and Severity Index), the SCORAD (SCORing Atopic Dermatitis), and the POEM (Patient-Oriented Eczema Measure) seem to have been adequately validated and are recommended for use in clinical practice and trials. The diagnostic tests to identify associated allergy or sensitization include skin-prick tests, determination of the specific IgE in serum using different assays, and atopy patch tests; in the case of suspected food allergy, a food challenge may be necessary to define the diagnosis.

To evaluate quality of life, tools exist that allow both the child’s and family’s impairment to be considered. In addition, several algorithms exist to help decide therapy on a step-wise basis. However, such guidelines and algorithms represent only an aid to the physician and not an obligatory directive, since the ultimate judgment regarding any therapy must be performed by the physician and tailored to individual needs. A clear and validated definition of eczema control would permit better monitoring of the disease, similar to the situation with asthma in recent years. Finally, the review examines the role of special textiles in diminishing Staphylococcus aureus skin superinfection, of house dust-mite avoidance measures, and of educational programs for patients and their families, which may all help improve eczema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. The International Study of Asthma and Allergy in Childhood (ISAAC) Steering Committee. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1125–32

    Google Scholar 

  2. Asher MI, Montefort S, Björkstén B, on behalf of the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733–43

    Article  PubMed  Google Scholar 

  3. Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151–60

    Article  PubMed  Google Scholar 

  4. Olesen AB, Bang K, Juul S, et al. Stable incidence of atopic dermatitis among children in Denmark during the 1990s. Acta Derm Venereol 2005; 85: 244–7

    PubMed  Google Scholar 

  5. Harris JM, Williams HC, White C, et al. Early allergen exposure and atopic eczema. Br J Dermatol 2007; 156: 698–704

    Article  PubMed  CAS  Google Scholar 

  6. Illi S, von Mutius E, Laus S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925–31

    Article  PubMed  Google Scholar 

  7. Ricci G, Patrizi A, Baldi E, et al. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J Am Acad Dermatol 2006; 55: 765–71

    Article  PubMed  Google Scholar 

  8. Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 1–24

    Google Scholar 

  9. Eigenmann P, Sicherer S, Borowski T, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101: e8

    Article  Google Scholar 

  10. Burks AW, James JM, Hiegel A, et al. Atopic dermatitis and food hypersensitivity reactions. J Pediatr 1998; 132: 132–6

    Article  PubMed  CAS  Google Scholar 

  11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92 Suppl.: 44–7

    Google Scholar 

  12. Wüthrich B. Atopic dermatitis flare provoked by inhalant allergens. Dermatologica 1989; 178: 51–3

    Article  PubMed  Google Scholar 

  13. Johansson SGO, Hourihane JO’B, Bousquet J, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813–24

    Article  PubMed  CAS  Google Scholar 

  14. Johansson SGO, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832–6

    Article  PubMed  CAS  Google Scholar 

  15. Novembre E, Cianferoni A, Lombardi E, et al. Natural history of ‘intrinsic’ atopic dermatitis. Allergy 2001; 56: 452–3

    Article  PubMed  CAS  Google Scholar 

  16. Wüthrich B, Schmid-Grendelmeier P. Natural history of AEDS. Allergy 2002; 57: 267–8

    Article  PubMed  Google Scholar 

  17. Wüthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome: epidemiology, natural course, and immunology of the IgE-associated (‘extrinsic’) and the nonallergic (‘intrinsic’) AEDS. J Investig Allergol Clin Immunol 2003; 13: 1–5

    PubMed  Google Scholar 

  18. Wallach D, Taïeb A, Tilles G. Histoire de la dermatite atopique. Paris: Masson Ed, 2005

    Google Scholar 

  19. Giardina E, Sinibaldi C, Chini L, et al. Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered 2006; 61: 229–36

    Article  PubMed  CAS  Google Scholar 

  20. Marenholz I, Nickel R, Rüschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006; 118: 866–71

    Article  PubMed  CAS  Google Scholar 

  21. Nomura T, Sandilands A, Akiyama M, et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007; 119: 434–40

    Article  PubMed  CAS  Google Scholar 

  22. Palmer CA, Ismail T, Lee SP, et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 2007; 120: 64–8

    Article  PubMed  CAS  Google Scholar 

  23. Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118: 3–21

    Article  PubMed  CAS  Google Scholar 

  24. Hanifin JM, Lobitz Jr WC. Newer concepts of atopic dermatitis. Arch Dermatol 1977; 113: 663–70

    Article  PubMed  CAS  Google Scholar 

  25. Williams HC, Burney PG, Hay RJ, et al. The UK Working Party’s diagnostic criteria for atopic dermatitis: I. Derivation of aminimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383–96

    Article  PubMed  CAS  Google Scholar 

  26. Bos JD, Van Leent EJ, Sillevis Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998; 4: 132–8

    Article  Google Scholar 

  27. Einchenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003; 49: 1088–95

    Article  Google Scholar 

  28. Williams HC. Atopic dermatitis. N Engl J Med 2005; 352: 2314–24

    Article  PubMed  CAS  Google Scholar 

  29. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23–31

    Google Scholar 

  30. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001; 10: 11–8

    CAS  Google Scholar 

  31. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure. Arch Dermatol 2004; 140: 1513–9

    Article  PubMed  Google Scholar 

  32. Dreborg S, Frew A. Position paper: allergen standardization and skin tests. Allergy 1993; 47 Suppl. 14: 48–82

    Google Scholar 

  33. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997; 100: 444–51

    Article  PubMed  CAS  Google Scholar 

  34. Niggemann B, Reibel S, Wahn U. The atopy patch test (APT): a useful tool for the diagnosis of food allergy in children with atopic dermatitis. Allergy 2000; 55: 281–5

    Article  PubMed  CAS  Google Scholar 

  35. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113: 805–19

    Article  PubMed  CAS  Google Scholar 

  36. Niggemann B, Rolinck-Werninghaus C, Mehl A, et al. Controlled oral food challenges in children–when indicated, when superfluous? Allergy 2005; 60: 865–70

    Article  PubMed  CAS  Google Scholar 

  37. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942–9

    Article  PubMed  CAS  Google Scholar 

  38. Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107–13

    Article  PubMed  CAS  Google Scholar 

  39. Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol 2001; 144: 104–10

    Article  PubMed  CAS  Google Scholar 

  40. Holme SA, Man I, Sharpe JL, et al. The Children’s Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285–90

    Article  PubMed  CAS  Google Scholar 

  41. McKenna SP, Whalley D, Abigail LD, et al. International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005; 14: 231–41

    Article  PubMed  Google Scholar 

  42. Ellis C, Luger T, Abeck D, et al., on behalf of the ICCAD II Faculty. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148 Suppl. 63: 3–10

    Article  PubMed  Google Scholar 

  43. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 2004; 50: 391–404

    Article  PubMed  Google Scholar 

  44. Abramovits W, Goldstein AM, Stevenson LC. Changing paradigms in dermatology: topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis. Clin Dermatol 2003; 21: 383–91

    Article  PubMed  Google Scholar 

  45. Abramovits W. A clinician paradigm in the treatment of atopic dermatitis. J Am Acad Dermatol 2005; 53 (1 Suppl. 1): S70–7

    Article  Google Scholar 

  46. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004; 59 Suppl. 78: 86–92

    Article  PubMed  Google Scholar 

  47. Darsow U, Lübbe J, Taïeb A, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19: 286–95

    Article  PubMed  CAS  Google Scholar 

  48. Akdis CA, Akdis M, Bieber T, et al., on behalf of the European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus report. Allergy 2006; 61: 969–87

    Article  PubMed  CAS  Google Scholar 

  49. Jøhnke H, Vach W, Norberg LA, et al. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol 2005; 153: 352–8

    Article  PubMed  Google Scholar 

  50. Taïeb A, Boralevi F. Atopic eczema in infants. In: Ring J, Przybilla B, Ruzicka T, editors. Handbook of atopic eczema. 2nd ed. Berlin: Springer-Verlag, 2006: 45–60

    Chapter  Google Scholar 

  51. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13–4

    CAS  Google Scholar 

  52. Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 2000; 142: 288–97

    Article  PubMed  CAS  Google Scholar 

  53. Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10–9

    Article  PubMed  CAS  Google Scholar 

  54. Oranje AP, Glazenburg EJ, Wolkerstorfer A, et al. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007; 157: 645–8

    Article  PubMed  CAS  Google Scholar 

  55. Berth-Jones J. Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 Suppl. 48: 25–30

    Article  PubMed  Google Scholar 

  56. Sugarman JL, Fluhr JW, Fowler AJ, et al. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003; 139: 1417–22

    Article  PubMed  Google Scholar 

  57. Eichenfield LF, Lucky AW, Boguniewicz M, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002; 46: 495–504

    Article  PubMed  Google Scholar 

  58. Gollnick H, Kaufmann R, Stough D, et al. Pimecrolimus cream 1% in the longterm management of adult atopic dermatitis: prevention of flare progression: a randomized controlled trial. Br J Dermatol 2008; 158: 1083–93

    Article  PubMed  CAS  Google Scholar 

  59. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled trials: what exactly are we measuring? J Invest Dermatol 2003; 120: 932–41

    Article  PubMed  CAS  Google Scholar 

  60. Schmitt J, Langan S, Williams HC, on behalf of the European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120: 1389–98

    Article  PubMed  Google Scholar 

  61. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2006; 117: S470–5

    Article  Google Scholar 

  62. Ramesh S. Food allergy overview in children. Clinic Rev Allerg Immunol 2008; 34: 217–30

    Article  Google Scholar 

  63. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev 2008 Jan 23; (1): CD005203

    Google Scholar 

  64. Ricci G, Bendandi B, Bellini F, et al. Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol 2007; 18: 245–9

    Article  PubMed  Google Scholar 

  65. Berger TG, Duvic M, Van Voorhees AS, et al., on behalf of the American Academy of Dermatology Association Task Force. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006; 54: 818–23

    Article  Google Scholar 

  66. Bieber T, Cork M, Ellis C, et al, for the Pediatric Advisory Committee of the Food and Drug Administration. Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology 2005; 211: 77–8

    CAS  Google Scholar 

  67. Fonacier L, Charlesworth EN, Spergel JM, et al. The black box warning for topical calcineurin inhibitors: looking outside the box. Ann Allergy Asthma Immunol 2006; 97: 117–20

    Article  PubMed  Google Scholar 

  68. Spergel JM, Leung DY. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep 2006 Jul; 6 (4): 270–4

    Article  PubMed  CAS  Google Scholar 

  69. Fleischer Jr AB. Black box warning for topical calcineurin inhibitors and the death of common sense. Dermatol Online J 2006; 12: 2

    PubMed  Google Scholar 

  70. Ricci G, Dondi A, Patrizi A. Role of topical calcineurin inhibitors on atopic dermatitis of children. Curr Med Chem 2007; 14: 1579–91

    Article  PubMed  CAS  Google Scholar 

  71. Ashcrotft DM, Chen LC, Garside R, et al. Topical pimecrolimus for eczema. Cochrane Database Syst Rev 2007; (4): CD005500

  72. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention [online]. Available from URL: http://www.ginasthma.org [Accessed 2009 May 25]

  73. Langan SM, Thomas KS, Williams HC. What is meant by a ‘flare’ in atopic dermatitis? A systematic review and proposal. Arch Dermatol 2006; 142: 1190–6

    Google Scholar 

  74. Diepgen TL, Stabler A, Hornstein OP. Textile intolerance in atopic eczema: a controlled clinical study. Z Hautkr 1990; 65: 907–10

    PubMed  CAS  Google Scholar 

  75. Bendsoe N, Bjornberg A, Asnes H. Itching from wool fibres in atopic dermatitis. Contact Derm 1987; 17: 21–2

    Article  PubMed  CAS  Google Scholar 

  76. Bunikowski R, Mielke ME, Skarabis H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105: 814–9

    Article  PubMed  CAS  Google Scholar 

  77. Ricci G, Dondi A, Patrizi A. Staphylococcus aureus overinfection in atopic dermatitis. J Pediatr Infect Dis 2008; 3: 83–90

    Google Scholar 

  78. Gauger A, Mempel M, Schekatz A, et al. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003; 207: 15–21

    Article  PubMed  Google Scholar 

  79. Gettings RL, Triplett BL. A new durable antimicrobial finish for textiles. Anaheim (CA): AATCC National Technical Conference Book of Papers, 1978: 259–61

    Google Scholar 

  80. Ricci G, Patrizi A, Bendandi B, et al. Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 2004; 150: 127–31

    Article  PubMed  CAS  Google Scholar 

  81. Ricci G, Patrizi A, Mandrioli P, et al. Evaluation of the antibacterial activity of a special silk textile in the treatment of atopic dermatitis. Dermatology 2006; 213: 224–7

    Article  PubMed  CAS  Google Scholar 

  82. Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan/chlorexidine combination therapy in atopic dermatitis. Skin Pharmacol Physiol 2007; 20: 71–6

    Article  PubMed  CAS  Google Scholar 

  83. Tupjer AR, De Monchy JGR, Coenraads PJ. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996; 97: 1064–70

    Article  Google Scholar 

  84. Sanda T, Yasue T. Effectiveness of house dust mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1991; 89: 653–7

    Article  Google Scholar 

  85. Nishioka K, Yasueda H, Saito H. Preventive effect of bedding encasement with microfine fibers on mite sensitization. J Allergy Clin Immunol 1998; 101: 28–32

    Article  PubMed  CAS  Google Scholar 

  86. Ricci G, Patrizi A, Specchia F, et al. Mite allergen (Der p1) levels in houses of children with atopic dermatitis: the relationship with allergometric tests. Br J Dermatol 1999; 140: 651–5

    Article  PubMed  CAS  Google Scholar 

  87. Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997; 99: 763–9

    Article  PubMed  CAS  Google Scholar 

  88. Nickel R, Kulig M, Forster J, et al. Sensitization to hen’s egg at the age of twelve months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997; 99: 613–7

    Article  PubMed  CAS  Google Scholar 

  89. Sasai K, Furukawa S, Muto T, et al. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Pediatr 1996; 128: 834–40

    Article  PubMed  CAS  Google Scholar 

  90. Platts-Mills TAE, Vervloet D, Thomas WR, et al. Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997; 100: S1–24

    Article  Google Scholar 

  91. Tan BB, Weald D, Strickland I, et al. Double blind controlled trial of effect of house dust mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15–8

    Article  PubMed  CAS  Google Scholar 

  92. Ricci G, Patrizi A, Specchia F, et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 2000; 143: 379–84

    Article  PubMed  CAS  Google Scholar 

  93. Oosting AJ, de Bruin-Weller MS, Terreehorst I, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebocontrolled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002; 110: 500–6

    Article  PubMed  Google Scholar 

  94. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, et al. The effect of encasings on quality of life in adult house dustmite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy 2005; 60: 888–93

    Article  PubMed  CAS  Google Scholar 

  95. Bussmann C, Maintz L, Hart J, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dustmite allergoid: a pilot study. Clin Exp Allergy 2007; 37: 1277–85

    Article  PubMed  CAS  Google Scholar 

  96. Cadario G, Galluccio AG, Pezza M, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 2007; 23: 2503–6

    Article  PubMed  CAS  Google Scholar 

  97. Stabb D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006; 332: 933–6

    Article  Google Scholar 

  98. Ricci G, Bendandi B, Aiazzi R, et al. Educational and medical programme for young children affected by atopic dermatitis and for their parents. Dermatol Psychosom 2004; 5: 187–92

    Article  Google Scholar 

  99. Grillo M, Gassner L, Marshman G, et al. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol 2006; 23: 428–36

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Bologna, via Massarenti 11, 40138, Bologna, Italy

    Giampaolo Ricci & Arianna Dondi

  2. Department of Clinical and Experimental Medicine, Division of Dermatology, University of Bologna, Bologna, Italy

    Annalisa Patrizi

Authors
  1. Giampaolo Ricci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arianna Dondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annalisa Patrizi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giampaolo Ricci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ricci, G., Dondi, A. & Patrizi, A. Useful tools for the Management of Atopic Dermatitis. AM J Clin Dermatol 10, 287–300 (2009). https://doi.org/10.2165/11310760-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11310760-000000000-00000

Keywords

Search

Navigation